Valbenazine ($Ingrezza)

VMAT2 inhibitor (reduces dopamine release)

Dosing

40mg 1 qhs x7days, then 2 qhs #60

Management

Risk of QTC prolongation

Preferred version of the two as it is once a day and had a larger effect size in the trials. If does not work or cannot afford, consider amantadine, levetiracetam, or ginkgo tebonin. VMAT2 Inhibitor.

EMR Text